-transparent.png){kind=logo}
A large scale study in general practice was set up to investigate the effects of transferring hypertensive patients from treatment with usually less than 1 g daily of methyldopa to atenolol ('Tenormin') 100 mg daily. The results demonstrate an improvement in blood pressure control with atenolol treatment and a reduction in the incidence of side-effects. The simple dosage regime, combined with proven effectiveness and a relative lack of side-effects makes atenolol a useful treatment for the hypertensive patient.
Related Publications
J A Tweed, and
B Mason, and
R Sleigh
January 1977,
Proceedings of the Royal Society of Medicine,
J A Tweed, and
B Mason, and
R Sleigh
January 1977,
Current medical research and opinion,
J A Tweed, and
B Mason, and
R Sleigh
September 1978,
East African medical journal,
J A Tweed, and
B Mason, and
R Sleigh
June 1990,
The British journal of general practice : the journal of the Royal College of General Practitioners,
J A Tweed, and
B Mason, and
R Sleigh
December 1975,
British journal of clinical pharmacology,
J A Tweed, and
B Mason, and
R Sleigh
June 1979,
The Practitioner,
J A Tweed, and
B Mason, and
R Sleigh
March 1993,
The British journal of general practice : the journal of the Royal College of General Practitioners,
J A Tweed, and
B Mason, and
R Sleigh
March 1984,
British medical journal (Clinical research ed.),
J A Tweed, and
B Mason, and
R Sleigh
October 2023,
Australian journal of general practice,
J A Tweed, and
B Mason, and
R Sleigh
January 1987,
Australian health review : a publication of the Australian Hospital Association,
